Drug intelligence / Profile preview

clonazepam

Development stage
Approved
Lead developer
Roche
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Clonazepam is a highly potent benzodiazepine used primarily as an anticonvulsant and anxiolytic. It is indicated for the treatment and prevention of various seizure disorders (including absence seizures and Lennox-Gastaut syndrome), panic disorder (including agoraphobia), akathisia, and acute catatonic reactions. Clonazepam acts by binding to the benzodiazepine site on GABA_A_ receptors in the central nervous system, enhancing the inhibitory effect of gamma-aminobutyric acid (GABA). This increases chloride ion influx into neurons, resulting in synaptic inhibition and CNS depression. The drug has a rapid onset of action (within 1 hour orally) with effects lasting 6–12 hours. Long-term use can lead to tolerance, dependence, and withdrawal symptoms[1][2][3][4].

Brand names
KlonopinKlonopin Wafer利福全利平靜
Other names
氯硝西泮
02

Targets

GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on clonazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clonazepam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call